Sign In | Join Free | My tjskl.org.cn
China Walvax Biotechnology Co., Ltd. logo
Walvax Biotechnology Co., Ltd.
Help Everyone Live a Healthy Life!
Verified Supplier

1 Years

Home > Meningococcal AC Conjugate Vaccine >

Lyophilized Meningococcal AC Conjugate Vaccine

Walvax Biotechnology Co., Ltd.
Trust Seal
Verified Supplier
Credit Check
Supplier Assessment

Lyophilized Meningococcal AC Conjugate Vaccine

Brand Name : Walvax

Model Number : Group A and C Meningococcal Polysaccharide Conjugate Vaccine

Certification : Certificated by China

Place of Origin : China

Payment Terms : L/C, T/T

Delivery Time : In stock: 20 workdays; To be produced: 4 months

Packaging Details : Vial, 1 dose. Each lyophilized vaccine is accompanied with 1 vial of 0.5ml diluent.

Dosage Form : Vial

Eligibles : Infants at the age of 3 to 12 months shall be given three doses (0.5ml per dose) from age of 3 months, at intervals of one month. Infants at the age of 13 to 24 months should follow recommended schedule of infants aged 3 to 12 months. Children at the age o

Presentation : Vial. 1 dose. Each lyophilized vaccine is accompanied with 1 vial of 0.5ml diluent

Schedule : The vaccine should be administered intramuscularly in the deltoid region.

Shelf Life : 24 months at 2-8℃

Package : Vial. 1 dose. Each lyophilized vaccine is accompanied with 1 vial of 0.5ml diluent

Contact Now

Prescribing Information

Product Name

Group A and C Meningococcal Polysaccharide Conjugate Vaccine

Description

Group A and C Meningococcal Polysaccharide Conjugate Vaccine is a lyophilized vaccine of Meningococcal capsular polysaccharide antigen, via polysaccharide activation and derivatization covalently bound to tetanus toxoid protein. This vaccine is presented as a white loose pellet, after reconstituted with diluent, the vaccine shall immediately turn into a clear, colorless solution.

One dose of 0.5ml contains:

Group A Meningococcal Polysaccharide……………….………………...………….10μg

Group C Meningococcal Polysaccharide……………………...………..……………10μg

Tetanus toxoid protein………………………………………………….……….33~120μg

Lactose ……………………………………………………………………………….3~5mg

Sodium Chloride ……………………………………………………………..3.75~4.75mg

Diluent: Sterile water for injection

Indications
The vaccine is indicated for the active immunization of organism, especially for the prevention for infants under the age of 2 years from diseases caused by Meningococcal Group A or C, such as cerebrospinal meningitis and septicemia (general infection).
The vaccine does not prevent diseases caused by other serotypes of Meningococcal nor infection caused by pathogen causing meningitis or septicemia.

Administration and Dosage
Reconstitute the vaccine with the accompanying diluents. Shake well and inject immediately. Each singe human dose is 0.5ml.
The vaccine should be administered intramuscularly in the deltoid region.
Infants at the age of 3 to 12 months shall be given three doses (0.5ml per dose) from age of 3 months, at intervals of one month.
Infants at the age of 13 to 24 months should follow recommended schedule of infants aged 3 to 12 months.
Children at the age of 2 to 5 years shall be given one dose (0.5ml).
Booster dose: The need for, or timing of a booster dose of the vaccine has not yet been determined.

Presentation

Vial. 1 dose. Each lyophilized vaccine is accompanied with 1 vial of 0.5ml diluent.

Shelf Life

24 months at 2-8℃.


Product Tags:

Lyophilized Meningococcal AC Conjugate Vaccine

      

Babies Meningococcal AC Conjugate Vaccine

      

Lyophilized Meningococcal Polysaccharide Conjugate Vaccine

      
Quality Lyophilized Meningococcal AC Conjugate Vaccine for sale

Lyophilized Meningococcal AC Conjugate Vaccine Images

Inquiry Cart 0
Send your message to this supplier
 
*From:
*To: Walvax Biotechnology Co., Ltd.
*Subject:
*Message:
Characters Remaining: (0/3000)